Non-peptidic, non-prenylic inhibitors of the prenyl protein-specific protease Rce1.
Several compounds designed as bisubstrate analogues of protein farnesyltransferase inhibited the prenyl protein-specific protease Rce1, qualifying them as lead structures for a novel class of non-peptidic, non-prenylic inhibitors of this protease.